Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Victhom Human Bionics Inc V.VHB



TSXV:VHB - Post by User

Post by JABombardieron Apr 21, 2009 12:56pm
150 Views
Post# 15933518

(VHB) SFU invention goes to market

(VHB) SFU invention goes to market

Victhom sera peut-être le next RIM au Canada???

https://www.sfu.ca/sfunews/files/spring2009/ahoffer04-09.jpg

SFU invention goes to market
April 12, 2009
Kinesiologist Andy Hoffer’s Neurostep—a device that dramatically improves the walking gait of people with disabilities such as hemiplegia and footdrop—will soon be on the market in Europe.

The pacemaker-like device is implanted inside the thigh and uses nerve cuffs to sense and stimulate nerve activity in the paralyzed leg. It gives greater mobility to those suffering from neurological disabilities such as stroke, multiple sclerosis, spinal cord injury or cerebral palsy.

In 1997, Hoffer created an SFU spin-off company, Neurostream Technologies, to commercialize the technology. Victhom Human Bionics bought the company in 2004 and recently obtained Europe’s CE Mark approval for the Neurostep™ System, the first approval of its kind for a closed-loop system (CLS) that uses signals sensed directly from peripheral nerves. With the approval, Victhom can now market the Neurostep in Europe and develop patient-training activities for hospitals and physicians.

Hoffer serves on Victhom’s Neurostep clinical and scientific advisory boards and remains active in Neurostep product development and clinical validation. He and his students in SFU’s Neurokinesiology Lab are now developing and testing (in pigs) a reversible, minimally invasive nerve stimulation electrode for "pacing" the human diaphragm muscle.

Their research, funded by an NSERC Idea-to-Innovation grant, could lead to a device that assists breathing and prevents diaphragm-muscle weakness or atrophy in critically ill patients who currently can only be kept alive with mechanical ventilation.

www.neurokin.sfu.ca/researchProject.php?s=381

<< Previous
Bullboard Posts
Next >>